tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Teva says well-positioned to achieve 2030 financial targets
PremiumThe FlyTeva says well-positioned to achieve 2030 financial targets
7d ago
Teva says ‘exciting growth’ emerging from biosimilar portfolio
Premium
The Fly
Teva says ‘exciting growth’ emerging from biosimilar portfolio
7d ago
Teva sees FY26 adjusted EPS $2.57-$2.77, consensus $2.77
Premium
The Fly
Teva sees FY26 adjusted EPS $2.57-$2.77, consensus $2.77
7d ago
Drugmakers use AI to help progress through trials, submissions, Reuters says
PremiumThe FlyDrugmakers use AI to help progress through trials, submissions, Reuters says
9d ago
Teva put volume heavy and directionally bearish
Premium
The Fly
Teva put volume heavy and directionally bearish
14d ago
Teva publishes Ajovy data in New England Journal of Medicine
Premium
The Fly
Teva publishes Ajovy data in New England Journal of Medicine
21d ago
Teva sees FY25 EPS $2.55-$2.65, consensus $2.63
PremiumThe FlyTeva sees FY25 EPS $2.55-$2.65, consensus $2.63
24d ago
Royalty Pharma, Teva enter agreement to accelerate development of TEV-‘408
Premium
The Fly
Royalty Pharma, Teva enter agreement to accelerate development of TEV-‘408
24d ago
Teva price target raised to $36 from $32 at Truist
Premium
The Fly
Teva price target raised to $36 from $32 at Truist
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100